207 WEST 25TH ST, 9TH FLOOR, NEW YORK, NY
Expands into Multi-Billion Dollar Precision Diagnostics Market with $30M Letter of Intent for a PanOmics Platform
Collaborate to Advance High-Impact Clinical Applications of Oxygen Monitoring Technologies
Announces 1-for-75 Reverse Stock Split
Submission of Matters to a Vote of Security Holders
Amendment No. 3 to Securities Purchase Agreement with Ascent Partners
Amendment No. 1 to Securities Purchase Agreement with Ascent Partners Fund
Announces Third Quarter Business and Financial Highlights
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Notice of Late Filing for Annual Report
Q3
Notice of Late Filing for Quarterly Report
Q2
Q1
FY 2024
Effectiveness Notice
Amended Registration Statement for Securities
Prospectus filed pursuant to Rule 424(b)(3)
S-1
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Definitive Information Statement
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Post-Effective Amendment to Registration Statement
Correspondence
Submission Upload